Skip to content

Adefovir dipivoxil

Hepsera (adefovir dipivoxil) is a small molecule pharmaceutical. Adefovir dipivoxil was first approved as Hepsera on 2002-09-20. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b.
Trade Name Hepsera
Common Name Adefovir dipivoxil
Indication chronic hepatitis b, hepatitis b
Drug Class Antivirals
Adefovir dipivoxil
Get full access now